SARACENI, FRANCESCO

SARACENI, FRANCESCO  

Mostra records
Risultati 1 - 20 di 24 (tempo di esecuzione: 0.051 secondi).
Titolo Data di pubblicazione Autore(i) File
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 1-gen-2018 Olivieri, J; Mosna, F; Pelosini, M; Fama, A; Rattotti, S; Giannoccaro, M; Carli, G; Tisi, Mc; Ferrero, S; Sgherza, N; Mazzone, Am; Marino, D; Calimeri, T; Loseto, G; Saraceni, F; Tomei, G; Sica, S; Perali, G; Codeluppi, K; Billio, A; Olivieri, A; Orciuolo, E; Matera, R; Stefani, Pm; Borghero, C; Ghione, P; Cascavilla, N; Lanza, F; Chiusolo, P; Finotto, S; Federici, I; Gherlinzoni, F; Centurioni, R; Fanin, R; Zaja, F; Fondazione Italiana Linfomi Postgraduate Master, Course.
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT 1-gen-2024 Gurnari, Carmelo; Koster, Linda; Baaij, Laurien; Heiblig, Mael; Yakoub-Agha, Ibrahim; Collin, Matthew; Passweg, Jakob; Bulabois, Claude E; Khan, Anjum; Loschi, Michael; Carnevale-Schianca, Fabrizio; Crisà, Elena; Caravelli, Daniela; Kuball, Jürgen; Saraceni, Francesco; Olivieri, Attilio; Rambaldi, Alessandro; Kulasekararaj, Austin G; Hayden, Patrick J; Badoglio, Manuela; Onida, Francesco; Scheid, Christof; Franceschini, Franco; Mekinian, Arsène; Savic, Sinisa; Voso, Maria Teresa; Drozd-Sokolowska, Joanna; Snowden, John A; Raj, Kavita; Alexander, Tobias; Robin, Marie; Greco, Raffaella; Mclornan, Donal P
Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT) 1-gen-2021 Saraceni, Francesco; Labopin, Myriam; Forcade, Edouard; Kröger, Nicolaus; Socié, Gerard; Niittyvuopio, Riitta; Cornelissen, Jan J; Labussière-Wallet, Hélène; Blaise, Didier; Choi, Goda; Byrne, Jenny L; Guillerm, Gaelle; Marchand, Tony; Esteve, Jordi; Bazarbachi, Ali; Savani, Bipin; Olivieri, Attilio; Nagler, Arnon; Mohty, Mohamad
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: A GITMO survey on 809 patients autografted in first complete remission 1-gen-2017 Saraceni, Francesco; Bruno, B.; Lemoli, R. M.; Meloni, G.; Arcese, W.; Falda, M.; Ciceri, F.; Alessandrino, E. P.; Specchia, G.; Scimè, R.; Raimondi, R.; Bacigalupo, A.; Bosi, A.; Onida, Fabrizio; Rambaldi, A.; Bonifazi, F.; Olivieri, Attilio
Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature 1-gen-2021 Scortechini, I.; Inglese, E.; Saraceni, F.; Poiani, M.; Mancini, G.; Urbano, G.; Lotito, A. F.; Colaneri, F.; Federici, I.; Polonara, G.; Olivieri, A.
Conditioning Regimens for Frail Patients with Acute Leukemia Undergoing Allogeneic Stem Cell Transplant: How to Strike Gently 1-gen-2021 Saraceni, Francesco; Scortechini, Ilaria; Fiorentini, Alessandro; Dubbini, Maria Vittoria; Mancini, Giorgia; Federici, Irene; Colaneri, Francesca Romana; Lotito, Antonio Federico; Guerzoni, Selene; Puglisi, Bruna; Olivieri, Attilio
Editorial: Reviews in hematologic malignancies 1-gen-2022 Saraceni, Francesco; More', Sonia
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 1-gen-2012 Capelli, Debora; Chiarucci, Martina; Saraceni, Francesco; Poloni, Antonella; Montanari, Mauro; Offidani, Massimo; Rupoli, Serena; Scortechini, Anna Rita; Gini, Guido; Scortechini, Ilaria; Leoni, Pietro; Olivieri, Attilio
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 1-gen-2020 Capelli, Debora; Saraceni, Francesco; Fiorentini, Alessandro; Chiarucci, Martina; Menotti, Diego; Poloni, Antonella; Discepoli, Giancarlo; Leoni, Pietro; Olivieri, Attilio
Focus on: Prognostic scores to predict stem cell mobilization 1-gen-2024 Olivieri, Attilio; Saraceni, Francesco; De Luca, Amalia
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 1-gen-2021 Tarantino, G; Saraceni, F; Mancini, G; Poiani, M; Maroni, L; Goteri, G; Scortechini, I; Fiorentini, A; Dubbini, Mv; Marini, F; Daretti, L; Marzioni, M; Bendia, E; Benedetti, A; Olivieri, A.
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 1-gen-2010 Debora, Capelli; Mancini, Giorgia; Chiarucci, Martina; Saraceni, Francesco; Poloni, Antonella; Trappolini, Silvia; Costantini, Benedetta; Montanari, Mauro; Gini, Guido; Scortechini, Ilaria; Leoni, Pietro; Olivieri, Attilio
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 1-gen-2016 MARINELLI BUSILACCHI, Elena; Costantini, Andrea; Viola, Nadia; Costantini, Benedetta; Poloni, Antonella; Olivieri, Jacopo; Saraceni, Francesco; Mancini, Giorgia; Olivieri, Attilio
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 1-gen-2014 Capelli, D; Attolico, I; Saraceni, Francesco; Mancini, Stefania; Scortechini, Ar; Poloni, Antonella; Bartocci, C; Viola, N; Pascale, S; Nuccorini, R; Chiarucci, Martina; Serrani, F; Pizzuti, M; Leoni, Pietro; Olivieri, Attilio
Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study 1-gen-2021 Zannetti, Beatrice Anna; Saraceni, Francesco; Cellini, Claudia; Fabbri, Elisabetta; Monaco, Federica; Guarini, Attilio; Laszlo, Daniele; Martino, Massimo; Olivieri, Attilio; Imola, Manuela; Tosi, Patrizia; Chiarucci, Martina; Zuffa, Eliana; Lanza, Francesco
Mobilization policy in multiple myeloma: Minimum target or law of redundancy? Two different approaches by the two sides of the Atlantic Ocean 1-gen-2016 Olivieri, Attilio; Saraceni, Francesco
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 1-gen-2014 Capelli, D; Chiarucci, Martina; Poloni, Antonella; Saraceni, Francesco; Mancini, Giorgia; Trappolini, Silvia; Troiani, E; Montanari, M; Scortechini, Ilaria; Offidani, M; Rupoli, S; Scortechini, Anna Rita; Gini, G; Discepoli, G; Leoni, Pietro; Olivieri, Attilio
Neurologic Complications IIN 169 Consecutive Allogeneic Stem Cell Transplants: Etiology, Clinical Syndromes and Outcome 1-gen-2020 Scortechini, I; Inglese, E; Poiani, M; Saraceni, F; Mancini, G; Urbano, G; Federici, I; Mariani, M; Micucci, G; Olivieri, A; Polonara, G
new monoclonal antibodies and tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemia 1-gen-2020 Lanza, F.; Maffini, E.; Saraceni, F.; Massari, E.; Rondoni, M.; Daghia, G.; Olivieri, A.; Cerchione, C.; Martinelli, G.
POOR RESPONSE TO FIRST BNT162B2 SARS-COV-2 VACCINE DOSE IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT 1-gen-2021 Saraceni, F; Fiorentini, A; More', S; Guerzoni, S; Puglisi, B; Corvaro, B; Menzo, S; Butini, L; Costantini, A; Viola, N; Lotito, Af; Colaneri, Fr; Scortechini, I; Mancini, G; Dubbini, Mv; Federici, I; Offidani, M; Olivieri, A